1. Home
  2. COCP vs GWAV Comparison

COCP vs GWAV Comparison

Compare COCP & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • GWAV
  • Stock Information
  • Founded
  • COCP 2006
  • GWAV 2002
  • Country
  • COCP United States
  • GWAV United States
  • Employees
  • COCP N/A
  • GWAV N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • GWAV Packaged Foods
  • Sector
  • COCP Health Care
  • GWAV Consumer Staples
  • Exchange
  • COCP Nasdaq
  • GWAV Nasdaq
  • Market Cap
  • COCP 15.4M
  • GWAV 12.6M
  • IPO Year
  • COCP N/A
  • GWAV N/A
  • Fundamental
  • Price
  • COCP $1.45
  • GWAV $0.19
  • Analyst Decision
  • COCP Strong Buy
  • GWAV
  • Analyst Count
  • COCP 1
  • GWAV 0
  • Target Price
  • COCP $7.00
  • GWAV N/A
  • AVG Volume (30 Days)
  • COCP 15.8K
  • GWAV 6.1M
  • Earning Date
  • COCP 05-27-2025
  • GWAV 05-23-2025
  • Dividend Yield
  • COCP N/A
  • GWAV N/A
  • EPS Growth
  • COCP N/A
  • GWAV N/A
  • EPS
  • COCP N/A
  • GWAV N/A
  • Revenue
  • COCP N/A
  • GWAV $33,315,859.00
  • Revenue This Year
  • COCP N/A
  • GWAV N/A
  • Revenue Next Year
  • COCP N/A
  • GWAV N/A
  • P/E Ratio
  • COCP N/A
  • GWAV N/A
  • Revenue Growth
  • COCP N/A
  • GWAV N/A
  • 52 Week Low
  • COCP $1.12
  • GWAV $0.12
  • 52 Week High
  • COCP $3.26
  • GWAV $44.55
  • Technical
  • Relative Strength Index (RSI)
  • COCP 52.12
  • GWAV 46.75
  • Support Level
  • COCP $1.46
  • GWAV $0.19
  • Resistance Level
  • COCP $1.79
  • GWAV $0.23
  • Average True Range (ATR)
  • COCP 0.16
  • GWAV 0.03
  • MACD
  • COCP 0.00
  • GWAV 0.00
  • Stochastic Oscillator
  • COCP 40.00
  • GWAV 31.14

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.

Share on Social Networks: